‘Electronic tongues’ may help diagnose early stage bladder cancer

By

New research presents a complex electronic device as a possible new, efficient, simple, and cost-effective way of detecting bladder cancer in its early stages and monitoring people living with bladder cancer.

In a quest to find a better way of diagnosing bladder cancer, Spain-based researchers from the Polytechnic University of Valencia (UPV), the La Fe Health Research Institute (IIS-La Fe) in Valencia, and the Centre for Biomedical Research in the fields of Bioengineering, Biomaterials and Nanomedicine in Madrid set out to develop a noninvasive method that harnessed the power of «taste-detecting» sensors. If you want to read more about this news, click here.

Posted in News, Science.
Share

Deja una respuesta

Tu dirección de correo electrónico no será publicada.

Related Posts

  •
    24 agosto, 2020

    COFEPRIS Evolves

  •
    18 junio, 2019

    5 Pediatric Orthopedic Devices you need to know

    The National Capital Consortium for Pediatric Device Innovation recently recognized five pediatric orthopedic devices that could improve scoliosis treatment, clubfoot assessment, and surgical imaging. If you want to read more about this news click here.

  •
    10 octubre, 2019

    AI-enhanced ECGs may soon assess overall health

    Scientists have trained an artificial intelligence tool to predict sex and estimate age from electrocardiogram readouts. They suggest that, with further development, the tool could soon be helping doctors to assess the overall health of their patients. An electrocardiogram, also known as an ECG or EKG, is a painless, simple test that records the electrical …

  •
    10 octubre, 2019

    Study: Abbott, Edwards may have mislabeled hundreds of patient deaths

    Abbott (NYSE:ABT) and Edwards Lifesciences (NYSE:EW) may have mislabeled patient deaths as injuries or device malfunctions in hundreds of FDA adverse event reports involving their transcatheter aortic or mitral valve replacement devices, according to a new study. The study by JAMA Internal Medicine editor Dr. Rita Redberg, former FDA unique device identification (UDI) external program manager Madris Tomes and others examined a total …